1st Quarter 2024
THIRD ANNUAL CONVENTION OF HEMERA
On Monday, April 22nd, the third Annual Convention of Hemera was held online, with over 50 members, partners, and investors attending, eager to learn in detail about the company’s achievements.
The meeting was an important opportunity to present, with the direct voices of the entire team, the advancements in research, the clinical progress achieved, and the developments in establishing the international network. During the meeting, the following individuals spoke:
1. Guido Fumagalli, President and Medical Director
2. Cristiana Vignoli, CEO
3. Massimo Locati, Scientific Director
4. Ilaria Decimo, Director of Research and Development
5. Francesco Bifari, Director of Therapy Development
6. Giuseppe Dastoli, Director of Clinical Development
7. Gianfranco Bellezza, Director of Scientific Marketing
INTERNATIONAL SCIENTIFIC DISSEMINATION
On February 28th and 29th, Hemera participated in the 17th Annual European Life Sciences CEO Forum, held in Zurich. This prestigious event, an integral part of the Sachs Spring Life Sciences Week, provided a significant opportunity for Hemera to connect with international investment funds and engage with other leaders and pioneers in the life sciences sector.
During the forum, relevant topics for the industry were discussed, including emerging innovations, sustainable growth strategies, and opportunities for international collaboration.
Participation in this event enabled Hemera to strengthen its network, stay updated on the latest market trends, and solidify its position as a key player in the life sciences landscape.